Conclusion IVP and MVP are effective and safe chemotherapeutic protocols for the treatment of advanced NSCLC patients.

• 结论以长春地辛为主的IVP及MVP方案为治疗晚期非小细胞肺癌较为有效而安全的化疗方案。